Abstract:LZ-B-1, a water-soluble peptidoglycan, was prepared from the fruiting bodies of Ling Zhi or Reishi medicinal mushroom, Ganoderma lucidum, by ultrafiltration, DEAE-Sepharose Fast-Flow column, and Sepharose CL-6B column. To develop functional food or pharmaceuticals using LZ-B-1 and to investigate the relationship between the structure and bioactivity of LZ-B-1, the composition and immunomodulatory capacity of LZ-B-1 were studied herein. The peptidoglycan had a relative molecular weight of 1.12 x 10(4) Da, and total carbohydrate and peptide percentages were determined to be similar to 94.2% and similar to 5.4%, respectively. The carbohydrate moiety was mainly composed of L-fucose, D-galatose, and D-glucose in a molar ratio of approximately 1:5:2, together with small amounts of L-arabinose and D-mannose. The peptide moiety mainly contained arginine, threonine, glycine, serine, and aspartic acid in a molar ratio of approximately 1:1:2:2:1. Methylation reaction and GC-MS analysis indicated that the carbohydrate moiety mainly consisted of 1,6-disubstituted-galactopyranosyl, 1,2,6-trisubstituted-galactopyranosyl, 1-substituted-fucopyranosyl, 1,3-disubstituted- glucopyranosyl, 1,4,6-trisubstituted-glucopyranosyl, and 1-substituted-glucopyranosyl. Mouse spleen cell proliferation assay in vitro showed that a concentration of 200 mu g/mL of LZ-B-1 was the optimum concentration to promote the proliferation of mouse spleen lymphocytes (MSLs). In general, the higher the mouse spleen cell proliferation rate, the stronger the immunomodulatory activity. How the peptidoglycan stimulates the proliferation of MSLs and the bioactivity-structure relationship requires more research.

Ganodermataceae: Natural Products and Their Related Pharmacological Functions.

Pharmacological Effects of Natural Ganoderma and Its Extracts on Neurological Diseases: A Comprehensive Review

A Comprehensive Review on the Chemical Composition, Pharmacology and Clinical Applications of Ganoderma

Neuropharmacological Effect and Clinical Applications of Ganoderma (Lingzhi).

Ganoderma lucidum and its pharmaceutically active compounds

Research Progress on the Biological Activity of Ganoderic Acids in Ganoderma lucidum over the Last Five Years

The Pharmacological Rationales and Molecular Mechanisms of Ganoderma lucidum Polysaccharides for the Therapeutic Applications of Multiple Diseases

Bioactive components, pharmacological properties and underlying mechanism of Ganoderma lucidum spore oil: A review

Characteristics of the Genome, Transcriptome and Ganoderic Acid of the Medicinal Fungus Ganoderma lingzhi

Ganoderma (Lingzhi) in Traditional Chinese Medicine and Chinese Culture

Preventive and Therapeutic Effect of Ganoderma (lingzhi) on Skin Diseases and Care

Ganoderma lucidum triterpenoids investigating their role in medicinal applications and genomic protection

Ganoderma lucidum: A Potent Pharmacological Macrofungus

MAJOR BIOACTIVE PROPERTIES OF GANODERMA POLYSACCHARIDES: A REVIEW

A Review of Ganoderma lucidum Polysaccharide: Preparations, Structures, Physicochemical Properties and Application

The Biological Activity of Ganoderma lucidum on Neurodegenerative Diseases: The Interplay between Different Active Compounds and the Pathological Hallmarks

Chemodiversity, pharmacological activity, and biosynthesis of specialized metabolites from medicinal model fungi Ganoderma lucidum

Immunomodulating Effect of Ganoderma (Lingzhi) and Possible Mechanism.

A Review on Management of Varius Disease by Traditional Chinese Medicine Ganoderma lucidum

Bioactivities and industrial standardization status of Ganoderma lucidum: A comprehensive review

Composition Analysis And Immunomodulatory Capacity Of Peptidoglycan From Ling Zhi Or Reishi Medicinal Mushroom, Ganoderma Lucidum (W. Curt.: Fr.) P. Karst. Strain 119 (Aphyllophoromycetideae)